Back to trial detailsIntake questionnaire
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Applying to UC San Diego Moores Cancer Center · La Jolla, California
Answer a few short questions to share with the research team.
0 of 3 answered